Abdullah, Nympha D.
HRN: 25-10-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2024
CO-AMOXICLAV 625MG (TAB)
05/08/2024
05/15/2024
PO
625mg
Bid
T/c Postpartum Infection
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes